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ABSTRACT 
 The study attempted to mimic the state of obesity in vitro using 
3T3-L1 adipocytes, since they represent white adipose tissue which is 
responsible for obesity and related disorders. 3T3-L1 adipocytes were 
exposed to various conditions occurring during obesity in vivo such as (a) 
hyperglycemia (using high glucose), (b) hypoxia (using cobalt chloride 
(CoCl2)) and (c) macrophage infiltration (using RAW 264.7  conditioned 
medium (RCM). The study also attempted to assess the effect of a potential 
anti-adipogenic phytochemical (chlorogenic acid (CGA) - isolated from 
Cichorium intybus) and plant extract (Gymnema sylvestre methanol extract 
(GSM)) for their activity on the above conditions mimicking obesity.   
 A state of 25 mM glucose has been known to induce insulin 
resistance and hypertrophy in 3T3-L1 cells. To probe the role of glucose 
during hyperglycemia in adipocytes, the effect of various concentrations of 
glucose (45 mM, 65 mM, 85 mM and 105 mM glucose) were analyzed on 
3T3-L1 adipocytes. Differentiation of preadipocytes in the presence of 105 
mM glucose (high glucose) exhibited a significant decrease in adipogenesis 
through inhibition of CCAAT/enhancer-binding proteins (C/EBP?), sterol 
regulatory element binding protein 1c (SREBP1c) and peroxisome 
proliferator-activated receptor (PPAR?). Cells in the presence of high glucose 
(105 mM) showed increased cell proliferation through phosphotidyl inositol 3 
kinase (PI3K) / protein kinase B (Akt) dependent pathway. Furthermore, 
inhibition of p27 validated the induction of hyperplasia of activated 
preadipocytes under the state of high glucose. Nitric oxide and reactive 
oxygen species (ROS) production was induced at this condition leading to an 
increase in the expression of toll-like receptor 4 (TLR4), tumor necrosis factor 
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? (TNF?) and nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF?B), thereby decreasing adiponectin production. This condition also 
showed insulin resistance through decrease in insulin receptor ? (IR?), 
whereas an increase in glucose uptake was observed through activation of 
glucose transporter 1 (GLUT1). To summarize, 3T3-L1 adipocytes treated 
with 105 mM glucose mimicked the state of hyperplasia during obesity. 
 In this study, hypoxia condition was mimicked by treating 
differentiated adipocytes with 150 µM CoCl2 for 6, 12 and 24 h wherein, 
CoCl2 when treated for 12 h showed maximum expression of HIF1?. In 
comparison to control, cells under the state of hypoxia were found to inhibit 
lipid accumulation via C/EBP?, leading to a decrease in adiponectin levels. 
Although, cytotoxicity was observed in cells treated with CoCl2, the 
expression of ROS was reduced in response to metabolic alteration during 
hypoxia. However, the levels of stress targets such as phosphorylated c-Jun 
N-terminal kinases (pJNK) and NF?B were found to increase. Also, CoCl2 
treatment showed no significant change in GLUT1 levels however, glycogen 
synthesis was found to increase showing signs of hypertrophy. To 
recapitulate, 3T3-L1 adipocytes treated with 150 µM CoCl2 exhibited 
conditions imitating hypoxia during obesity. 
 To mimic the condition of macrophage infiltration in adipocytes 
during obesity, the effect of RCM on differentiated adipocytes was 
investigated for 6, 12 and 24 h. Maximum NO and ROS release along with an 
increase in inflammatory markers such as TNF?, pJNK and phosphorylated 
extracellular regulated kinase (pERK1/2) was observed at 24 h of RCM 
treatment. Further, RCM treatment induced cytotoxicity in adipocytes and the 
increase in lipid content due to significant increase in lipofuscin content 
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indicated the state of senescence.  This was validated by an increase in 
senescence markers such as p53, p21, retinoblastoma protein (pRb), p27 and 
cyclin D1. The cells treated with RCM showed an inhibition of insulin 
signalling, since expression of insulin receptor substrate 1(IRS1) and PI3K 
were found to decrease. The study clearly shows that RCM induced 
inflammation and senescence in adipocytes, thereby mimicking the state of 
macrophage infiltration induced senescence. 
 CDK5 is a protein kinase specifically expressed in the adipose 
tissue during obesity and is known to be activated by TNF? and various 
cytokines. Cells differentiated in the presence of 105 mM glucose and 
adipocytes treated with RCM for 24 h increased CDK5 levels significantly in 
comparison to control cells. But differentiated adipocytes when treated with 
150 µM CoCl2 for 12 h showed reduced levels of ROS and TNF? with no 
significant change in CDK5 levels, signifying the role of ROS and TNF? in 
the regulation of CDK5 expression. 
 As obesity is a complex disorder, it would be advisable to use 
treatments possessing multiple effects, thereby minimizing side effects. 
Bioactive molecules have an advantage of optimisation of the dosage for 
consumption. In contrast, the plant extracts are expected to show strong 
potential as activities are exhibited from a mixture of active molecules. Hence 
the study attempts to study the bioactivity exhibited by a CGA and GSM.    
 CGA (100 ng/ml) exhibited significant down regulation of PPAR?, 
C/EBP?, phosphorylated hormone sensitive lipase (pHSL) and CDK5 along 
with an increase in adiponectin level. CGA (100 ng/ml) showed effective 
regulation of targets involved during obesity, and hence was selected for 
understanding its role on the three in vitro conditions mimicking obesity. The 
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cells differentiated with 105 mM glucose (hyperplasia model) when treated 
with CGA (100 ng/ml) showed significant decrease in GLUT1 expression and 
induced glycogen synthesis through increase in phosphorylated glycogen 
synthase kinase (pGSK3? - inactive form). CGA also inhibited CDK5 protein 
which was induced during hyperplasia. Treatment of CGA (100 ng/ml) in 
cells induced with hypoxia, showed an inhibition of HIF1?, pJNK and NF?B 
leading to an increase in adiponectin levels. Adipocytes treated with RCM in 
the presence of CGA (100 ng/ml) reduced ROS production and lipofuscin 
levels along with decrease in p53, p21 and pRb levels, showing reversal of 
senescence. The increased expression of CDK5 in RCM treated adipocytes 
was also reduced during CGA treatment. 
 GSM (10 µg/ml) exhibited optimum bioactivity by inhibition of 
adipogenesis through down regulation of PPAR?, SREBP1c and CDK5; 
however, an increase in C/EBP? and adiponectin was observed. GSM also 
inhibited the lipid protecting protein, perilipin with no significant change in 
pHSL levels. GSM was also investigated for its role on the three developed 
conditions mimicking obesity and results from the study clearly showed the 
potential of GSM in alleviating the various targets of obesity.  
 In conclusion, the present study has established in vitro models 
mimicking the conditions of obesity, characterized by hypertrophy/ 
hyperplasia, hypoxia and macrophage infiltration using 3T3-L1 adipocytes. 
The molecular programming involved during these conditions has also been 
elucidated through gene and protein expression studies. The therapeutic 
options for the developed conditions of obesity have been evaluated wherein 
CGA (100 ng/ml) and GSM (10 µg/ml) have been shown to be effective in 
alleviating various cellular targets involved during obesity. 
